As the expression data does not provide evidence for a conclusive role of IRF1 in breast cancer, to determine whether downregulation of IRF1 was unambiguously associated with change in cell number and apoptosis, IRF1+I4 transduced fibroblast cells from patients with no tumor history were investigated in cell culture assays. This evidence concerns the gene IRF1 and breast carcinoma.